Publicaciones en las que colabora con María jesuś Serramía (19)

2020

  1. Gold nanoparticles crossing blood-brain barrier prevent HSV-1 infection and reduce herpes associated amyloid-βsecretion

    Journal of Clinical Medicine, Vol. 9, Núm. 1

2018

  1. Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion

    Bioconjugate Chemistry, Vol. 29, Núm. 5, pp. 1584-1594

  2. Study of non-covalent interactions on dendriplex formation: Influence of hydrophobic, electrostatic and hydrogen bonds interactions

    Colloids and Surfaces B: Biointerfaces, Vol. 162, pp. 380-388

2016

  1. Improved Efficiency of Ibuprofen by Cationic Carbosilane Dendritic Conjugates

    Molecular Pharmaceutics, Vol. 13, Núm. 10, pp. 3427-3438

2015

  1. Fluorescein labelled cationic carbosilane dendritic systems for biological studies

    European Polymer Journal, Vol. 71, pp. 61-72

  2. HIV-1 reservoir dynamics after vaccination and antiretroviral therapy interruption are associated with dendritic cell vaccine-induced T cell responses

    Journal of Virology, Vol. 89, Núm. 18, pp. 9189-9199

  3. In vivo delivery of siRNA to the brain by carbosilane dendrimer

    Journal of Controlled Release, Vol. 200, pp. 60-70

  4. Polycationic carbosilane dendrimer decreases angiogenesis and tumor-associated macrophages in tumor-bearing mice

    RSC Advances, Vol. 5, Núm. 126, pp. 104110-104115

  5. Prevention vaginally of HIV-1 transmission in humanized BLT mice and mode of antiviral action of polyanionic carbosilane dendrimer G2-S16

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, Núm. 6, pp. 1299-1308

  6. Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission

    Nanomedicine, Vol. 10, Núm. 6, pp. 899-914

2012

  1. Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile

    Journal of Controlled Release, Vol. 161, Núm. 3, pp. 949-958

2011

  1. Erratum: Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16 (Pharmaceutical Research DOI: 10.1007/s11095-008-9776-z)

    Pharmaceutical Research

  2. Transition-metal complexes based on a sulfonate-containing N-donor ligand and their use as HIV antiviral agents

    European Journal of Inorganic Chemistry, pp. 1657-1665

2010

  1. Gene therapy in HIV-infected cells to decrease viral impact by using an alternative delivery method

    ChemMedChem, Vol. 5, Núm. 6, pp. 921-929

  2. Globular carbosilane dendrimers with mannose groups at the periphery: synthesis, characterization and toxicity in dendritic cells

    Tetrahedron, Vol. 66, Núm. 18, pp. 3326-3331

  3. Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer

    Biomaterials, Vol. 31, Núm. 33, pp. 8749-8758

2009

  1. Carbosilane dendrimers peripherally functionalized with dansyl fluorescence tags and their cellular internalization studies

    Organic and Biomolecular Chemistry, Vol. 7, Núm. 15, pp. 3079-3085

  2. Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16

    Pharmaceutical Research, Vol. 26, Núm. 3, pp. 577-586

2006

  1. Novel water-soluble carbosilane dendrimers: Synthesis and biocompatibility

    European Journal of Inorganic Chemistry, pp. 1388-1396